JVJeffrey A. Vanegas

Jeffrey A. Vanegas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jeffrey A. Vanegas has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Xue Gao

    Department of Chemical and Biomolecular Engineering, University of Pennsylvania, Philadelphia, PA, USA.

    3 shared publications
  • Jie Yang

    Tianjin Medical University Cancer Institute and Hospital, State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, National Clinical Research Center for Cancer, Tianjin Institute of Immunology, Tianjin’s Clinical Research Center for Cancer, School of Basic Medical Sciences, Tianjin Medical University , Tianjin 300070

    2 shared publications
  • Advaith Peddi

    Department of BioSciences, Rice University, Houston, USA

    1 shared publication
  • Alan Cabrera

    Department of Bioengineering, Rice University, Houston, USA

    1 shared publication
  • Anatoly B. Kolomeisky

    Rice University

    1 shared publication
  • Angela Lin

    Department of BioSciences, Rice University, Houston, Texas 77005, United States

    1 shared publication

Latest Publications

  • Multiplex Base-Editing Enables Combinatorial Epigenetic Regulation for Genome Mining of Fungal Natural Products

    by Fanglong Zhao, Chunxiao Sun, Zhiwen Liu, Alan Cabrera, Mario Escobar, Shunyu Huang, Qichen Yuan, Qiuyue Nie, Kevin Lee Luo, Angela Lin, et al.

    Genome mining of cryptic natural products (NPs) remains challenging, especially in filamentous fungi, owing to their complex genetic regulation. Increasing evidence indicates that several epigenetic modifications often act cooperatively to control fungal gene transcription, yet the ability to predictably manipulate multiple genes simultaneously is still largely limited. Here, we developed a multiplex base-editing (MBE) platform that significantly improves the capability and throughput of fungal genome manipulation, leading to the simultaneous inactivation of up to eight genes using a single transformation. We then employed MBE to inactivate three negative epigenetic regulators combinatorially in Aspergillus nidulans, enabling the activation of eight cryptic gene clusters compared to the wild-type strains. A group of novel NPs harboring unique cichorine and polyamine hybrid chemical scaffolds were identified, which were not reported previously. We envision our scalable and efficient MBE platform can be readily applied in other filamentous fungi for genome mining of novel NPs, providing a powerful approach for the exploitation of fungal chemical diversity.


  • Engineered LwaCas13a with enhanced collateral activity for nucleic acid detection

    by Jie Yang, Yang Song, Xiangyu Deng, Jeffrey A. Vanegas, Zheng You, Yuxuan Zhang, Zhengyan Weng, Lori Avery, Kevin D. Dieckhaus, Advaith Peddi, et al.

    Clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated protein 13 (Cas13) has been rapidly developed for nucleic-acid-based diagnostics by using its characteristic collateral activity. Despite the recent progress in optimizing the Cas13 system for the detection of nucleic acids, engineering Cas13 protein with enhanced collateral activity has been challenging, mostly because of its complex structural dynamics. Here we successfully employed a novel strategy to engineer the Leptotrichia wadei (Lwa)Cas13a by inserting different RNA-binding domains into a unique active-site-proximal loop within its higher eukaryotes and prokaryotes nucleotide-binding domain. Two LwaCas13a variants showed enhanced collateral activity and improved sensitivity over the wild type in various buffer conditions. By combining with an electrochemical method, our variants detected the SARS-CoV-2 genome at attomolar concentrations from both inactive viral and unextracted clinical samples, without target preamplification. Our engineered LwaCas13a enzymes with enhanced collateral activity are ready to be integrated into other Cas13a-based platforms for ultrasensitive detection of nucleic acids.


  • Open Access

    A general theoretical framework to design base editors with reduced bystander effects

    by Qian Wang, Jie Yang, Zhicheng Zhong, Jeffrey A. Vanegas, Xue Gao, Anatoly B. Kolomeisky

    Base editors (BEs) hold great potential for medical applications of gene therapy. However, high precision base editing requires BEs that can discriminate between the target base and multiple bystander bases within a narrow active window (4 – 10 nucleotides). Here, to assist in the design of these optimized editors, we propose a discrete-state stochastic approach to build an analytical model that explicitly evaluates the probabilities of editing the target base and bystanders. Combined with all-atom molecular dynamic simulations, our model reproduces the experimental data of A3A-BE3 and its variants for targeting the “TC” motif and bystander editing. Analyzing this approach, we propose several general principles that can guide the design of BEs with a reduced bystander effect. These principles are then applied to design a series of point mutations at T218 position of A3G-BEs to further reduce its bystander editing. We verify experimentally that the new mutations provide different levels of stringency on reducing the bystander editing at different genomic loci, which is consistent with our theoretical model. Thus, our study provides a computational-aided platform to assist in the scientifically-based design of BEs with reduced bystander effects.